NEW YORK (GenomeWeb News) – Shareholders of Ventana Medical Systems have tendered 25.5 million shares, or 70.5 percent of Ventana’s outstanding stock, as of the close of the tender offer last night.

 

In January, after several months of pursuing Ventana, Roche finally reached an agreement to acquire the tissue-based diagnostics products firm for approximately $3.4 billion, or $89.50 per share. That was up from its previously rejected bid of $75 per share.